FEMASITOL 2.0 sachets, this new product contains an equal amount of myo-inositol as its predecessor Femasitol, to restore ovulation, optimize IVF procedures and prevent /manage gestational diabetes. The substitution of folic acid with 5-MTHF, the biologically active molecule, makes it possible to bypass MTHFR, and thus restart maternal-fetal metabolic processes and prevent neural tube defects, particularly in PCOS women at particular risk of folate deficiency. (Food for Special Medical Purposes, “FSMP”)